Form 4: Aspira Women's Health Director Converts Restricted Stock Units to Common Shares

Aspira Women's Health Inc. Director John Phillip Ragard converted 4,844 restricted stock units into common stock following their vesting on June 4, 2025, increasing his direct beneficial ownership to 134,734 shares.

Summary

• John Phillip Ragard, a Director of Aspira Women's Health Inc. (AWHL), reported a change in beneficial ownership via a Form 4 filing.
• On June 4, 2025, 4,844 restricted stock units (RSUs) granted to Mr. Ragard on August 22, 2024, vested and subsequently converted into common stock.
• This transaction resulted in an acquisition of 4,844 shares of common stock at a price of $0, as it represents the conversion of previously granted equity compensation.
• Following this conversion, Mr. Ragard's direct beneficial ownership of Aspira Women's Health Inc. common stock increased to 134,734 shares.

Sentiment

Score: 5

Explanation: The filing reports a routine vesting and conversion of restricted stock units for a director, which is a standard compensation event and does not indicate significant positive or negative sentiment regarding the company's performance or outlook.

Positives

• The vesting and conversion of restricted stock units into common stock increases the direct beneficial ownership of Director John Phillip Ragard, further aligning his interests with those of the company's shareholders.

Future Outlook

NA

Industry Context

This Form 4 filing details a routine insider transaction related to equity compensation and does not provide information relevant to broader industry trends or competitive dynamics.

Stakeholder Impact

• Shareholders: The increase in direct stock ownership by a director enhances alignment between management and shareholder interests.

Key Dates

Recommendation

Keywords

Aspira Women's Health, AWHL, Form 4, insider transaction, beneficial ownership, restricted stock units, RSU, stock vesting, director compensation